Contribution: Industrial Research Assistance Program – Contributions to Firms
AbCellera Biologics Inc.
$2,617,300.00
Vertical Integration of Antibody Discovery for Next-Generation Biotherapeutics
FY 2018-19 · 2019-01-01
Summary
This project will develop, validate, and integrate new technologies to create a platform for the discovery of therapeutic antibodies against any target class, and with industry-leading speed, throughput, and efficiency.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
838509446
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2019-01-01 | 2018-19 | $2,617,300.00 |
| 1 | 2019-01-01 | 2018-19 | $2,617,300.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 274 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 274 jours.
Agreement End Date
2022-03-31
Agreement Number
921989
Agreement Start Date
2019-01-01
Agreement Title
Vertical Integration of Antibody Discovery for Next-Generation Biotherapeutics
Agreement Title (French)
Intégration verticale de la découverte d'anticorps pour les biothérapies de prochaine génération
Agreement Type
Contribution
Agreement Value
$2,617,300.00
Amendment Date
2020-10-01
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will develop, validate, and integrate new technologies to create a platform for the discovery of therapeutic antibodies against any target class, and with industry-leading speed, throughput, and efficiency.
Description (French)
Ce projet développera, validera et intégrera de nouvelles technologies afin de créer une plate-forme pour la découverte d'anticorps thérapeutiques contre n'importe quelle classe cible, avec une vitesse, un débit et une efficacité inégalés dans l'industrie.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Granville
Federal Riding (French)
Vancouver Granville
Federal Riding Number
59036
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
838509446
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
AbCellera Biologics Inc.
Recipient Operating Name
AbCellera
Recipient Postal Code
V5Y 0A1
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2018-2019-Q4-921989
